| Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients J Hadjadj, N Yatim, L Barnabei, A Corneau, J Boussier, N Smith, H Péré, ... Science 369 (6504), 718-724, 2020 | 3051 | 2020 |
| RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells N Yatim, H Jusforgues-Saklani, S Orozco, O Schulz, R Barreira da Silva, ... Science 350 (6258), 328-334, 2015 | 593 | 2015 |
| Dying cells actively regulate adaptive immune responses N Yatim, S Cullen, ML Albert Nature Reviews Immunology 17 (4), 262-275, 2017 | 397 | 2017 |
| RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis S Orozco, N Yatim, MR Werner, H Tran, SY Gunja, SWG Tait, ML Albert, ... Cell Death & Differentiation 21 (10), 1511-1521, 2014 | 312 | 2014 |
| Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy R Barreira da Silva, ME Laird, N Yatim, L Fiette, MA Ingersoll, ML Albert Nature immunology 16 (8), 850-858, 2015 | 300 | 2015 |
| Widespread mitochondrial depletion via mitophagy does not compromise necroptosis SWG Tait, A Oberst, G Quarato, S Milasta, M Haller, R Wang, M Karvela, ... Cell reports 5 (4), 878-885, 2013 | 299 | 2013 |
| Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients DM Smadja, CL Guerin, R Chocron, N Yatim, J Boussier, N Gendron, ... Angiogenesis 23, 611-620, 2020 | 266 | 2020 |
| Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency E Giampazolias, B Zunino, S Dhayade, F Bock, C Cloix, K Cao, A Roca, ... Nature cell biology 19 (9), 1116-1129, 2017 | 232 | 2017 |
| Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection N Smith, P Goncalves, B Charbit, L Grzelak, M Beretta, C Planchais, ... Nature immunology 22 (11), 1428-1439, 2021 | 145 | 2021 |
| Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity A Alloatti, DC Rookhuizen, L Joannas, JM Carpier, S Iborra, ... Journal of Experimental Medicine 214 (8), 2231-2241, 2017 | 125 | 2017 |
| RIPK3 activation leads to cytokine synthesis that continues after loss of cell membrane integrity SL Orozco, BP Daniels, N Yatim, MN Messmer, G Quarato, H Chen-Harris, ... Cell reports 28 (9), 2275-2287. e5, 2019 | 100 | 2019 |
| Platelet activation in critically ill COVID-19 patients N Yatim, J Boussier, R Chocron, J Hadjadj, A Philippe, N Gendron, ... Annals of intensive care 11, 1-12, 2021 | 71 | 2021 |
| Dying to replicate: the orchestration of the viral life cycle, cell death pathways, and immunity N Yatim, ML Albert Immunity 35 (4), 478-490, 2011 | 70 | 2011 |
| Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients A Courties, J Boussier, J Hadjadj, N Yatim, L Barnabei, H Péré, D Veyer, ... Scientific Reports 11 (1), 11886, 2021 | 44 | 2021 |
| Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity N Smith, C Possémé, V Bondet, J Sugrue, L Townsend, B Charbit, ... Nature communications 13 (1), 7254, 2022 | 40 | 2022 |
| Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak L Frumholtz, JD Bouaziz, M Battistella, J Hadjadj, R Chocron, D Bengoufa, ... British Journal of Dermatology 185 (6), 1176-1185, 2021 | 40 | 2021 |
| Lupus anticoagulant single positivity during the acute phase of COVID‐19 is not associated with venous thromboembolism or In‐hospital mortality N Gendron, MA Dragon‐Durey, R Chocron, L Darnige, G Jourdi, ... Arthritis & Rheumatology 73 (11), 1976-1985, 2021 | 34 | 2021 |
| Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection N Yatim, J Boussier, P Tetu, N Smith, T Bruel, B Charbit, L Barnabei, ... Science Advances 7 (34), eabg4081, 2021 | 34 | 2021 |
| Sarcoidosis post-anti-PD-1 therapy, mimicking relapse of metastatic melanoma in a patient undergoing complete remission N Yatim, C Mateus, P Charles La Revue de Médecine Interne 39 (2), 130-133, 2018 | 30 | 2018 |
| Severe COVID-19 is associated with hyperactivation of the alternative complement pathway J Boussier, N Yatim, A Marchal, J Hadjadj, B Charbit, C El Sissy, N Carlier, ... Journal of Allergy and Clinical Immunology 149 (2), 550-556. e2, 2022 | 29 | 2022 |
